Senate Finance Committee Urges CMS Not to Reduce “Protected Classes” Under Part D


In a February 5, 2014 letter signed by every member of the Senate Finance Committee (13 Democrats; 11 Republicans), Committee members “strongly urge[d]” CMS not to finalize proposed Part D changes that would reduce the number of “protected classes” of drugs under the Part D prescription drug benefit, citing concerns that the proposed change would result in decreased beneficiary access to medications used to treat mental health problems. We previously reported on CMS’s proposed Part D changes in our January 13, 2014 edition of Health Headlines, available here.

Written by:

Published In:


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.